Mark Bodmer
2020
In 2020, Mark Bodmer earned a total compensation of $1.2M as Chief Scientific Officer at Evelo Biosciences, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $228,800 |
|---|---|
| Option Awards | $483,250 |
| Salary | $440,000 |
| Total | $1,152,050 |
Bodmer received $483.3K in option awards, accounting for 42% of the total pay in 2020.
Bodmer also received $228.8K in non-equity incentive plan and $440K in salary.
Rankings
In 2020, Mark Bodmer's compensation ranked 8,025th out of 13,090 executives tracked by ExecPay. In other words, Bodmer earned more than 38.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,025 out of 13,090 | 39th |
Division Manufacturing | 3,404 out of 5,624 | 40th |
Major group Chemicals And Allied Products | 1,377 out of 2,257 | 39th |
Industry group Drugs | 1,199 out of 1,957 | 39th |
Industry Pharmaceutical Preparations | 892 out of 1,462 | 39th |
Source: SEC filing on April 26, 2021.
Bodmer's colleagues
We found two more compensation records of executives who worked with Mark Bodmer at Evelo Biosciences in 2020.